Schedule 13G ownership disclosure

Upstream Bio Inc

Common Stock, par value $0.001 per share · CUSIP: 91678A107

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Decheng Capital Global Life Sciences Fund IV, L.P.

    Shares: 3,085,293.00 · Class: 5.8%

  • Decheng Capital Management IV (Cayman), LLC

    Shares: 3,085,293.00 · Class: 5.8%

  • Decheng Capital Global Healthcare Fund (Master), LP

    Shares: 200,000.00 · Class: 0.4%

  • Decheng Capital Global Healthcare GP, LLC

    Shares: 200,000.00 · Class: 0.4%

  • Xiangmin Cui

    Shares: 3,285,293.00 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-004199
Form type
SCHEDULE 13G
Filer
Decheng Capital Global Life Sciences Fund IV, L.P.
CIK
CIK 1834150
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub